https://ipam.peptidesandiego.com/blogs/news 2026-08-03T09:02:01-04:00 weekly https://ipam.peptidesandiego.com/blogs/news/fda-tightens-screws-on-semaglutide-compounding-what-it-means-for-online-peptide-buyers 2026-07-19T23:01:10-04:00 weekly https://ipam.peptidesandiego.com/blogs/news/retatrutide-compounding-under-fda-scrutiny-after-medpage-today-investigation 2026-07-23T09:03:37-04:00 weekly https://ipam.peptidesandiego.com/blogs/news/aspens-generic-semaglutide-in-canada-a-regulatory-precedent-for-retatrutide-compounding-access 2026-07-27T09:02:56-04:00 weekly https://ipam.peptidesandiego.com/blogs/news/retatrutide-compounding-loophole-fda-panel-vote-and-pharmacy-access-vs-glp-1-shortage-restrictions 2026-07-30T09:03:28-04:00 weekly https://ipam.peptidesandiego.com/blogs/news/fda-panel-vote-on-peptides-what-eased-restrictions-mean-for-semaglutide-compounding-and-online-access 2026-08-03T09:02:01-04:00 weekly